Programmes for Enhanced Recovery after Surgery (ERAS) accelerate recovery, reduce morbidity, and shorten hospital stay in a wide range of surgical specialties. We established a standardised multimodal ERAS pathway for patients who were being treated by free tissue transfer for head and neck cancer to evaluate its benefit. Our primary outcome was duration of hospital stay, and secondary outcomes included complications, number of days to first mobilisation, and readmission rates. We compared 100 consecutive patients who followed the ERAS programme with a control group of 40 consecutive patients who had free tissue transfer before the ERAS programme was introduced.
http://ift.tt/2jc9pEp
Αρχειοθήκη ιστολογίου
-
►
2023
(256)
- ► Φεβρουαρίου (140)
- ► Ιανουαρίου (116)
-
►
2022
(1695)
- ► Δεκεμβρίου (78)
- ► Σεπτεμβρίου (142)
- ► Φεβρουαρίου (155)
-
►
2021
(5507)
- ► Δεκεμβρίου (139)
- ► Σεπτεμβρίου (333)
- ► Φεβρουαρίου (628)
-
►
2020
(1810)
- ► Δεκεμβρίου (544)
- ► Σεπτεμβρίου (32)
- ► Φεβρουαρίου (28)
-
►
2019
(7684)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (53)
- ► Φεβρουαρίου (2841)
- ► Ιανουαρίου (2803)
-
►
2018
(31838)
- ► Δεκεμβρίου (2810)
- ► Σεπτεμβρίου (2870)
- ► Φεβρουαρίου (2420)
- ► Ιανουαρίου (2395)
-
▼
2017
(31987)
- ► Δεκεμβρίου (2460)
-
▼
Νοεμβρίου
(2546)
-
▼
Νοε 20
(70)
- AHNS Series: Do you know your guidelines? Guidelin...
- Clinical diagnosis and treatment outcomes for para...
- Table of Contents
- Editorial Board
- Prevalence of type I sensitization to alpha-gal in...
- ABBV-085, an Antibody Drug Conjugate, in Subjects ...
- Clinicopathologic Predictive Factors of Cervical L...
- Specific Organ Targeted Vestibular Physiotherapy: ...
- Specific Organ Targeted Vestibular Physiotherapy: ...
- Enhanced recovery in patients having free tissue t...
- Are patients satisfied with the head and neck skin...
- Immunoresolvents signaling molecules at intersecti...
- Laryngeal candidiasis: our experience from sixty b...
- Fetal Exposure to Maternal Pregnancy Complications...
- Innate Immune Activation by cGMP-AMP Nanoparticles...
- Critical Functions of IRF4 in B and T Lymphocytes ...
- In This Issue [IN THIS ISSUE]
- Pillars Article: Requirement for the Transcription...
- The Structural Basis for Complement Inhibition by ...
- Galectin-1: A Jack-of-All-Trades in the Resolution...
- Complement Regulatory Protein Factor H Is a Solubl...
- Cutting Edge: Anti-TIM-3 Treatment Exacerbates Pul...
- Palmitate Conditions Macrophages for Enhanced Resp...
- Induction of Systemic Autoimmunity by a Xenobiotic...
- CK12a, a CCL19-like Chemokine That Orchestrates bo...
- Thymic-Specific Serine Protease Limits Central Tol...
- IFN-{lambda}4 Attenuates Antiviral Responses by En...
- Transient BAFF Blockade Inhibits Type 1 Diabetes D...
- Factor H-IgG Chimeric Proteins as a Therapeutic Ap...
- Anti-CD20 Antibody Prevents Red Blood Cell Alloimm...
- IL-17A-Induced PLET1 Expression Contributes to Tis...
- {gamma}{delta} T Cells Are Required for the Induct...
- Orchestrating Role of Apoptosis Inhibitor of Macro...
- Listeria monocytogenes Replicate in Bone Marrow-De...
- Correction
- Language-specific strategy for programming hearing...
- Pediatric type 1 cartilage tympanoplasty outcomes:...
- Mannose-binding lectin deficiency associated with ...
- The association of maternal prenatal vitamin D lev...
- Hydroxychloroquine as a steroid-sparing agent in a...
- Schnitzler syndrome with IgG gammopathy and elevat...
- Advances in rhinitis—models and mechanisms
- Dexamethasone for inpatient childhood asthma exace...
- Visually Augmented Targeted Combination Light Ther...
- Endoscopic Evaluation of Duodenal Polyposis in Pat...
- A Study of Epacadostat and Nivolumab in Combinatio...
- MRI of Esophagus Cancer
- Muscle Dysfunction in Gastrointestinal or Hepatobi...
- Nivolumab for the Reversal of Squamous Dysplasia i...
- Reply to the Letter to the Editor: “Extracapsular ...
- Peroxisome proliferator activated receptor-gamma s...
- Free gracilis muscle transfer for smile reanimatio...
- Intensity-modulated radiotherapy for elderly patie...
- Safety and effectiveness of endovascular embolizat...
- Letter to the Editor regarding “Extracapsular diss...
- Circadian profiling reveals higher histamine plasm...
- Secondary erythromelalgia: a tryptophan dietary su...
- An extension of a multicenter, randomized, split-f...
- Regressed melanocytic nevi secondary to pembrolizu...
- Syringe lubricant and adverse reactions
- Autoantibodies to full body vascular cell junction...
- Anti-desmogleins autoantibodies detected by ELISA ...
- The “Duvic regimen” for erythrodermic flares secon...
- Polymorphous presentation of subcutaneous phaeohyp...
- Changing practices of hair relaxer use among black...
- Human papillomavirus-associated cutaneous disease ...
- Atomic force microscopy for biomechanical and stru...
- Interleukin-17 Alters the Biology of Many Cell Typ...
- Laudation for Dr. Alexander Berghaus
- The Genetic Basis of Seborrheic Dermatitis: A Review
-
▼
Νοε 20
(70)
- ► Σεπτεμβρίου (2605)
- ► Φεβρουαρίου (2785)
- ► Ιανουαρίου (2830)
-
►
2016
(5308)
- ► Δεκεμβρίου (2118)
- ► Σεπτεμβρίου (877)
- ► Φεβρουαρίου (41)
- ► Ιανουαρίου (39)
Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174
Δευτέρα 20 Νοεμβρίου 2017
Enhanced recovery in patients having free tissue transfer for head and neck cancer: does it make a difference?
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου